Adult-onset vanishing white matter disease due to a novel compound heterozygous EIF2B2 mutation: a case report and brief review
- PMID: 39762463
- DOI: 10.1007/s10072-025-07990-6
Adult-onset vanishing white matter disease due to a novel compound heterozygous EIF2B2 mutation: a case report and brief review
Abstract
Background and objectives: Vanishing white matter disease (VWMD) is an autosomal recessive leukoencephalopathy caused by mutations in the EIF2B1-5 genes, typically rare in adulthood. We present a case of adult-onset VWMD with a novel EIF2B2 mutation.
Methods: We collected the patient's clinical data, cerebrospinal fluid (CSF) results, laboratory tests, imaging features, genetic analysis, and follow-up data over a 4-year period.
Results: A 40-year-old male patient presented with difficulty walking and leg pain. Neurological examination revealed acalculia, slow reaction times, and ataxia. Magnetic resonance imaging (MRI) scans showed diffuse, symmetric lesions with cerebrospinal fluid-like signals predominantly in the subcortical, periventricular, and cerebellar white matter. Genetic testing identified a compound heterozygous mutation in EIF2B2, consisting of a novel nonsense mutation (c.378 T > G, p.Tyr126*) and a reported missense mutation (c.818A > G, p.Lys273Arg) (NM_014239.4).
Discussions: This report highlights the diverse phenotypic manifestations of VWMD and underscores the importance of considering EIF2B2 mutations in adult male patients with bilaterally symmetric hyperintensities in white matter and slowly progressive symptoms.
Keywords: Adult onset; Compound heterozygous mutations; EIF2B2; Vanishing white matter disease.
© 2025. Fondazione Società Italiana di Neurologia.
Conflict of interest statement
Declarations. Ethical statement: The authors declare that there are no conflicts of interest. The study, which involved human participants, was approved by the Ethics Committee of the Sun Yat-sen University for Human Study and was conducted in accordance with the principles of the 1975 Declaration of Helsinki. The informed and publication consent have been submitted as supplemental material. Competing interests: The authors have no competing interests to declare that are relevant to the content of this article. Conflict of interest: The authors declare that there are no conflicts of interest.
References
-
- van der Knaap MS, Pronk JC, Scheper GC (2006) Vanishing white matter disease. Lancet Neurol 5(5):413–423. https://doi.org/10.1016/S1474-4422(06)70440-9 - DOI - PubMed
-
- van der Knaap MS, Leegwater PAJ, Könst AAM, Visser A, Naidu S, Oudejans CBM, Schutgens RBH, Pronk JC (2002) Mutations in each of the five subunits of translation initiation factor eIF2B can cause leukoencephalopathy with vanishing white matter. Ann Neurol 51(2):264–270. https://doi.org/10.1002/ana.10112 - DOI - PubMed
-
- van der Knaap MS (1997) A new leukoencephalopathy with vanishing white matter. Neurology 48(4):845–55. https://doi.org/10.1212/wnl.48.4.845 - DOI - PubMed
-
- Ding XQ, Bley A, Ohlenbusch A, Kohlschütter A, Fiehler J, Zhu W, Lanfermann H (2012) Imaging evidence of early brain tissue degeneration in patients with vanishing white matter disease: A multimodal MR study. J Magn Reson Imaging 35(4):926–932. https://doi.org/10.1002/jmri.23517 - DOI - PubMed
-
- Labauge P, Horzinski L, Ayrignac X, Blanc P, Vukusic S, Rodriguez D, Mauguiere F, Peter L, Goizet C, Bouhour F, Denier C, Confavreux C, Obadia M, Blanc F, Sèze Jd, Fogli A, Boespflug-Tanguy O (2009) Natural history of adult-onset eIF2B-related disorders: a multi-centric survey of 16 cases. Brain 132(8):2161–2169. https://doi.org/10.1093/brain/awp171 - DOI - PubMed
MeSH terms
Substances
Grants and funding
- 82071294/National Natural Science Foundation of China
- 32000391/National Natural Science Foundation of China
- 2314050003660/Basic and Applied Basic Research Foundation of Guangdong Province
- 2020B1212060017/Guangdong Provincial Key Laboratory of Diagnosis and Treatment of Major Neurological Diseases
- 2015B050501003/the Southern China International Cooperation Base for Early Intervention and Functional Rehabilitation of Neurological Diseases
LinkOut - more resources
Full Text Sources